Six things to know:
1. RTI’s second-quarter revenues were boosted from a $10.1 million global contribution made from the acquisition of Paradigm Spine, which closed in March.
2. Gross profit in the second quarter was $44.7 million, which made up 54.4 percent of revenues. Profit increased 49 percent compared to the $30 million posted in the second quarter of 2018.
3. Net income applicable to common shareholders was $700,000 or $0.01 per fully diluted common share. This was an increase from the $6.4 million in net losses in the second quarter of 2018.
4. Second-quarter adjusted EBITDA was $9.9 million, which was 12 percent of revenue.
5. The company maintained its full-year revenue estimates of $325 million to $335 million.
“We’re very pleased with the double-digit topline growth of our legacy spine hardware portfolio, particularly as we work to establish a new sales channel to drive the growth of our Novel Therapies portfolio, which includes coflex,” said RTI Surgical President and CEO Camille Farhat.
More articles on devices:
SeaSpine launches implant platform for revision spinal fusions
Zimmer Biomet Q2 spine sales down 6.2%: 5 things to know
Life Spine receives FDA 510(k) clearance for expandable spacer implant
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
